Literature DB >> 19760258

Intratumoral patterns of clonal evolution in gliomas.

Ana Luísa Vital1, Maria Dolores Tabernero, Inês Crespo, Olinda Rebelo, Hermínio Tão, Fernando Gomes, Maria Celeste Lopes, Alberto Orfao.   

Abstract

Few studies have explored the patterns of clonal evolution in gliomas. Here, we investigate the cytogenetic patterns of intratumoral clonal evolution of gliomas and their impact on tumor histopathology and patient survival. Cytogenetic analysis of 90 gliomas was performed in individual tumor cells (>200 cells/tumor) using multicolor (N = 16 probes) interphase-FISH. Overall, chromosome gains were more frequent than chromosome losses. Gains of chromosome 7 and/or EGFR amplification were detected in 91% of the cases, whereas del(9p21) (77%) and del(10q23) (78%) were the most frequent chromosome losses. Virtually, all cases (99%) showed >or=2 tumor cell clones, with higher numbers among high- versus low-grade gliomas (p = 0.001). Nine different cytogenetic patterns were found in the ancestral tumor clones. In most gliomas, ancestral clones showed abnormalities of chromosome 7, 9p, and/or 10q and cytogenetic evolution consisted of acquisition of additional abnormalities followed by tetraploidization. Conversely, early tetraploidization was associated with low-grade astrocytomas-2/3 pilocytic and 3/6 grade II diffuse astrocytomas-and combined loss of 1p36/19q13 with oligodendrogliomas, respectively; both aberrations were associated with a better patient outcome (p = 0.03). Overall, our results support the existence of different pathways of intratumoral evolution in gliomas.

Entities:  

Mesh:

Year:  2009        PMID: 19760258     DOI: 10.1007/s10048-009-0217-x

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  59 in total

1.  High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH).

Authors:  Christine E Fuller; Huamin Wang; Wei Zhang; Gregory N Fuller; Arie Perry
Journal:  J Neuropathol Exp Neurol       Date:  2002-12       Impact factor: 3.685

2.  The complexity of the 7p12 amplicon in human astrocytic gliomas: detailed mapping of 246 tumors.

Authors:  L Liu; K Ichimura; E H Pettersson; H M Goike; V P Collins
Journal:  J Neuropathol Exp Neurol       Date:  2000-12       Impact factor: 3.685

3.  Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme.

Authors:  C Lopez-Gines; M Cerda-Nicolas; R Gil-Benso; A Pellin; J A Lopez-Guerrero; R Callaghan; R Benito; P Roldan; J Piquer; J Llacer; J Barbera
Journal:  Clin Neuropathol       Date:  2005 Sep-Oct       Impact factor: 1.368

4.  Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?

Authors:  José María Sayagués; María Dolores Tabernero; Angel Maíllo; Ana Espinosa; Ana Rasillo; Pedro Díaz; Juana Ciudad; Antonio López; Marta Merino; Jesús María Gonçalves; Angel Santos-Briz; Francisco Morales; Alberto Orfao
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

Review 5.  The epidermal growth factor receptor pathway: a model for targeted therapy.

Authors:  Maurizio Scaltriti; José Baselga
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

Review 6.  Genetic pathways to primary and secondary glioblastoma.

Authors:  Hiroko Ohgaki; Paul Kleihues
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 7.  Second messenger systems in human gliomas.

Authors:  Roger E McLendon; Kristi Turner; Kathryn Perkinson; Jeremy Rich
Journal:  Arch Pathol Lab Med       Date:  2007-10       Impact factor: 5.534

8.  Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas.

Authors:  Kavita S Reddy
Journal:  Cancer Genet Cytogenet       Date:  2008-07-15

9.  Cytogenetic analyses in 81 patients with brain gliomas: correlation with clinical outcome and morphological data.

Authors:  Filip Kramar; Zuzana Zemanova; Kyra Michalova; Libuse Babicka; Sarka Ransdorfova; Petr Hrabal; Petr Kozler
Journal:  J Neurooncol       Date:  2007-06-14       Impact factor: 4.130

10.  Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

Authors:  Naoki Shinojima; Kenji Tada; Shoji Shiraishi; Takanori Kamiryo; Masato Kochi; Hideo Nakamura; Keishi Makino; Hideyuki Saya; Hirofumi Hirano; Jun-Ichi Kuratsu; Koji Oka; Yasuji Ishimaru; Yukitaka Ushio
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

View more
  12 in total

Review 1.  Studying a complex tumor: potential and pitfalls.

Authors:  Siyuan Zheng; Milan G Chheda; Roel G W Verhaak
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

2.  Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays.

Authors:  Inês Crespo; Ana Luísa Vital; Ana Belen Nieto; Olinda Rebelo; Hermínio Tão; Maria Celeste Lopes; Catarina Resende Oliveira; Pim J French; Alberto Orfao; María Dolores Tabernero
Journal:  J Mol Diagn       Date:  2011-08-30       Impact factor: 5.568

3.  Gene expression profiles of human glioblastomas are associated with both tumor cytogenetics and histopathology.

Authors:  Ana Luísa Vital; Maria Dolores Tabernero; Abel Castrillo; Olinda Rebelo; Hermínio Tão; Fernando Gomes; Ana Belen Nieto; Catarina Resende Oliveira; Maria Celeste Lopes; Alberto Orfao
Journal:  Neuro Oncol       Date:  2010-05-18       Impact factor: 12.300

Review 4.  The cellular origin for malignant glioma and prospects for clinical advancements.

Authors:  Hui Zong; Roel G W Verhaak; Peter Canoll
Journal:  Expert Rev Mol Diagn       Date:  2012-05       Impact factor: 5.225

5.  Loss of Heterozygosity of 9p Is Associated with Poorer Survival in Patients with Gliomas.

Authors:  Tingfen Huang; Shufa Li; Zhen Yang; Jicheng Liu; Yunwei Han
Journal:  Mol Neurobiol       Date:  2015-11-19       Impact factor: 5.590

6.  Amplified and homozygously deleted genes in glioblastoma: impact on gene expression levels.

Authors:  Inês Crespo; Hermínio Tão; Ana Belen Nieto; Olinda Rebelo; Patrícia Domingues; Ana Luísa Vital; Maria del Carmen Patino; Marcos Barbosa; Maria Celeste Lopes; Catarina Resende Oliveira; Alberto Orfao; María Dolores Tabernero
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

7.  Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma.

Authors:  David H Gutmann; Michael D McLellan; Ibrahim Hussain; John W Wallis; Lucinda L Fulton; Robert S Fulton; Vincent Magrini; Ryan Demeter; Todd Wylie; Cyriac Kandoth; Jeffrey R Leonard; Abhijit Guha; Christopher A Miller; Li Ding; Elaine R Mardis
Journal:  Genome Res       Date:  2012-12-05       Impact factor: 9.043

8.  Clinical neuropathology practice guide 1-2013: molecular subtyping of glioblastoma: ready for clinical use?

Authors:  Adelheid Woehrer; Christine Marosi; Georg Widhalm; Stefan Oberndorfer; Josef Pichler; Johannes A Hainfellner
Journal:  Clin Neuropathol       Date:  2013 Jan-Feb       Impact factor: 1.368

9.  Glioblastoma multiforme: a look inside its heterogeneous nature.

Authors:  Maria-Del-Mar Inda; Rudy Bonavia; Joan Seoane
Journal:  Cancers (Basel)       Date:  2014-01-27       Impact factor: 6.639

10.  Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine.

Authors:  Linping Hu; Kun Ru; Li Zhang; Yuting Huang; Xiaofan Zhu; Hanzhi Liu; Anders Zetterberg; Tao Cheng; Weimin Miao
Journal:  Biomark Res       Date:  2014-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.